Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 6Unknown 4Terminated 4Recruiting 4Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Urinary Bladder Neoplasms 1Thymoma 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1SCLC, Extensive Stage 1Resectable Esophageal Cancer 1Rectal Neoplasms 1Pathologic Complete Response 1Oropharyngeal Neoplasms 1Neoplasms 1NSCLC 1Mouth Neoplasms 1Lung Neoplasms 1Esophageal Squamous Cell Carcinoma 1Efficacy and Safety of Short-course Radiotherapy in Total Neoadjuvant Therapy Combined With Enlonstobart for pMMR Locally Advanced Rectal Cancer 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 33Pemetrexed 26Drug Therapy 22Cisplatin 21osimertinib 18aflutinib 10Surgical Procedures, Operative 10Paclitaxel 10Docetaxel 10tislelizumab 9pembrolizumab 8anlotinib 7Specimen Handling 7Magnetic Resonance Spectroscopy 7Bevacizumab 7130-nm albumin-bound paclitaxel 7toripalimab 6cemiplimab 6Immunotherapy 6sintilimab 5ensartinib 5durvalumab 5Radiotherapy 5Platinum Compounds 5Nivolumab 5trametinib 4aumolertinib 4Observation 4Cetuximab 4Blood Specimen Collection 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Carcinoma, Non-Small-Cell Lung × Chemoradiotherapy × Clear all
NCT06998719 2025-05-31

ACCESS

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Not yet recruiting
80 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡